← Back to headlines
Innate Pharma Reports GAAP EPS of -€0.55 and Revenue of €9.01M
Innate Pharma announced its financial results, reporting a GAAP Earnings Per Share (EPS) of -€0.55 and a total revenue of €9.01 million.
26 Mar, 11:48 — 26 Mar, 11:48
Sources
Showing 1 of 1 sources
